Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1 (original) (raw)

• Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10–29.
  Article PubMed Google Scholar
• Li D, Xie K, Wolff R, Abbruzzese JL . Pancreatic cancer. Lancet 2004; 363: 1049–1057.
  Article CAS PubMed Google Scholar
• Murphy JD, Adusumilli S, Griffith KA, Ray ME, Zalupski MM, Lawrence TS et al. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2007; 68: 801–808.
  Article CAS PubMed Google Scholar
• Ouyang H, Wang P, Meng Z, Chen Z, Yu E, Jin H et al. Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine. Pancreas 2011; 40: 120–125.
  Article CAS PubMed PubMed Central Google Scholar
• Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007; 25: 1960–1966.
  Article CAS PubMed Google Scholar
• Kim VN, Han J, Siomi MC . Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009; 10: 126–139.
  Article CAS PubMed Google Scholar
• Iorio MV, Croce CM . MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848–5856.
  Article CAS PubMed PubMed Central Google Scholar
• Jamieson NB, Morran DC, Morton JP, Ali A, Dickson EJ, Carter CR et al. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin Cancer Res 2012; 18: 534–545.
  Article CAS PubMed Google Scholar
• Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008; 13: 48–57.
  Article CAS PubMed Google Scholar
• Li X, Zhang Y, Ding J, Wu K, Fan D . Survival prediction of gastric cancer by a seven-microRNA signature. Gut 2009; 59: 579–585.
  Article PubMed Google Scholar
• Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007; 26: 4442–4452.
  Article CAS PubMed Google Scholar
• Esquela-Kerscher A, Slack FJ . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259–269.
  Article CAS PubMed Google Scholar
• Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007; 67: 1424–1429.
  Article CAS PubMed Google Scholar
• Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J et al. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis 2011; 32: 1183–1189.
  Article CAS PubMed Google Scholar
• Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, Selves J et al. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem 2010; 56: 1107–1118.
  Article CAS PubMed Google Scholar
• Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N et al. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 2009; 9: 293–301.
  Article CAS PubMed PubMed Central Google Scholar
• Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Korner H et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008; 7: 2591–2600.
  Article CAS PubMed Google Scholar
• Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J . miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31: 766–776.
  Article CAS PubMed Google Scholar
• Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 2011; 61: 278–289.
  Article PubMed Google Scholar
• Wilting SM, van Boerdonk RA, Henken FE, Meijer CJ, Diosdado B, Meijer GA et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer 2010; 9: 167.
  Article PubMed PubMed Central Google Scholar
• Takai D, Jones PA . The CpG island searcher: a new WWW resource. In Silico Biol 2003; 3: 235–240.
  CAS PubMed Google Scholar
• Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006; 38: 1378–1385.
  Article CAS PubMed PubMed Central Google Scholar
• Keely PJ, Westwick JK, Whitehead IP, Der CJ, Parise LV . Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 1997; 390: 632–636.
  Article CAS PubMed Google Scholar
• Chan AY, Coniglio SJ, Chuang YY, Michaelson D, Knaus UG, Philips MR et al. Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 2005; 24: 7821–7829.
  Article CAS PubMed Google Scholar
• Grijelmo C, Rodrigue C, Svrcek M, Bruyneel E, Hendrix A, de Wever O et al. Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells. Cell Signal 2007; 19: 1722–1732.
  Article CAS PubMed Google Scholar
• Kanwal R, Gupta S . Epigenetics and cancer. J Appl Physiol 2012; 109: 598–605.
  Article Google Scholar
• Kong KL, Kwong DL, Chan TH, Law SY, Chen L, Li Y et al. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2011; 61: 33–42.
  Article PubMed Google Scholar
• Zhang Y, Yan LX, Wu QN, Du ZM, Chen J, Liao DZ et al. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res 2011; 71: 3552–3562.
  Article CAS PubMed Google Scholar
• Kubo T, Toyooka S, Tsukuda K, Sakaguchi M, Fukazawa T, Soh J et al. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin Cancer Res 2011; 17: 4965–4974.
  Article CAS PubMed Google Scholar
• Ando T, Yoshida T, Enomoto S, Asada K, Tatematsu M, Ichinose M et al. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 2009; 124: 2367–2374.
  Article CAS PubMed Google Scholar
• Griffin JF, Smalley SR, Jewell W, Paradelo JC, Reymond RD, Hassanein RE et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990; 66: 56–61.
  Article CAS PubMed Google Scholar
• Qiu RG, Chen J, Kirn D, McCormick F, Symons M . An essential role for Rac in Ras transformation. Nature 1995; 374: 457–459.
  Article CAS PubMed Google Scholar
• Rathinam R, Berrier A, Alahari SK . Role of Rho GTPases and their regulators in cancer progression. Front Biosci 2011; 17: 2561–2571.
  Article Google Scholar
• Heid I, Lubeseder-Martellato C, Sipos B, Mazur PK, Lesina M, Schmid RM et al. Early requirement of Rac1 in a mouse model of pancreatic cancer. Gastroenterology 2011; 141: 730 e711–717.
  Article Google Scholar
• Medina PP, Slack FJ . Inhibiting microRNA function in vivo. Nat Methods 2009; 6: 37–38.
  Article CAS PubMed Google Scholar
• Mardin WA, Mees ST . MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma? Ann Surg Oncol 2009; 16: 3183–3189.
  Article PubMed Google Scholar
• Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P, Taubert H . Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 2010; 126: 73–80.
  Article CAS PubMed Google Scholar
• Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901–1908.
  Article CAS PubMed Google Scholar
• Hummel R, Hussey DJ, Haier J . MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 2010; 46: 298–311.
  Article CAS PubMed Google Scholar
• Lekanne Deprez RH, Fijnvandraat AC, Ruijter JM, Moorman AF . Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions. Anal Biochem 2002; 307: 63–69.
  Article CAS PubMed Google Scholar
• Wang P, Chen Z, Meng ZQ, Fan J, Luo JM, Liang W et al. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function. Carcinogenesis 2009; 30: 1497–1506.
  Article CAS PubMed Google Scholar
• Shi WD, Meng ZQ, Chen Z, Lin JH, Zhou ZH, Liu LM . Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis. Cancer Lett 2009; 283: 84–91.
  Article CAS PubMed Google Scholar
• Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T et al. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst 2005; 97: 1734–1746.
  Article CAS PubMed Google Scholar
• Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009; 69: 1135–1142.
  Article CAS PubMed Google Scholar
• Chen L, Chan TH, Yuan YF, Hu L, Huang J, Ma S et al. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Invest 2010; 120: 1178–1191.
  Article CAS PubMed PubMed Central Google Scholar
• Nuovo GJ, Elton TS, Nana-Sinkam P, Volinia S, Croce CM, Schmittgen TD . A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets. Nat Protoc 2009; 4: 107–115.
  Article CAS PubMed PubMed Central Google Scholar
• Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM, Chen J . The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 2010; 31: 1726–1733.
  Article CAS PubMed Google Scholar